Assenagon Asset Management
AGN

Assenagon Asset Management’s Allergan plc AGN Stock Holding History

Assenagon Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,101
Closed -$1.17M – 1069
2019
Q4 		$1.17M Sell
6,101
-1,771,274
-100% -$320M 0.01% 551
2019
Q3 		$299M Buy
1,777,375
+1,432,555
+415% +$233M 2% 9
2019
Q2 		$57.7M Buy
344,820
+243,035
+239% +$33.7M 0.43% 49
2019
Q1 		$14.9M Sell
101,785
-273,362
-73% -$39.6M 0.14% 139
2018
Q4 		$50.1M Buy
375,147
+30,313
+9% +$4.97M 0.57% 46
2018
Q3 		$65.7M Buy
344,834
+302,474
+714% +$55.6M 0.65% 39
2018
Q2 		$7.06M Buy
+42,360
New +$6.8M 0.08% 203
2018
Q1 		– Sell
-124,231
Closed -$20.3M – 808
2017
Q4 		$20.3M Buy
124,231
+107,500
+643% +$19.3M 0.21% 105
2017
Q3 		$3.43M Buy
+16,731
New +$3.89M 0.03% 291

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Assenagon Asset Management's AGN Position: Q1 2020 in Review

Assenagon Asset Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 6,101 shares — an estimated $1.17M sold.

Assenagon Asset Management first reported a position in AGN in Q3 2017 and held it in 9 quarters. The position peaked at $299M in Q3 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Assenagon Asset Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Assenagon Asset Management sold 6,101 Allergan plc shares in Q1 2020, an estimated $1.17M.
  • Assenagon Asset Management first reported a position in Allergan plc in Q3 2017 and held it in 9 quarters.
  • Assenagon Asset Management's Allergan plc position peaked at $299M in Q3 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Assenagon Asset Management's 13F filing for Q1 2020, filed 17 Apr 2020.